Toru Kanno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Toru Kanno has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
David Mackay
<!--label omitted: 2-->Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey GU24 0NF, United Kingdom2
1 shared publicationGinette Wilsden
<!--label omitted: 2-->Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey GU24 0NF, United Kingdom2
1 shared publicationJunsuke Shirai
<!--label omitted: 1-->Department of Exotic Disease, National Institute of Animal Health, 6-20-1, Josuihoncho, Kodaira, Tokyo 187-0022, Japan,1 and
1 shared publicationMakoto Yamakawa
<!--label omitted: 1-->Department of Exotic Disease, National Institute of Animal Health, 6-20-1, Josuihoncho, Kodaira, Tokyo 187-0022, Japan,1 and
1 shared publicationPaul Kitching
<!--label omitted: 2-->Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey GU24 0NF, United Kingdom2
1 shared publicationReiko Yamazoe
<!--label omitted: 1-->Department of Exotic Disease, National Institute of Animal Health, 6-20-1, Josuihoncho, Kodaira, Tokyo 187-0022, Japan,1 and
1 shared publication
Latest Publications
- 1 April 1999
- Published by American Society for Microbiology in Journal of Virology
- Vol. 73 (4) , 2710-2716
Mapping the Genetic Determinants of Pathogenicity and Plaque Phenotype in Swine Vesicular Disease Virus
A series of recombinant viruses were constructed using infectious cDNA clones of the virulent J1’73 (large plaque phenotype) and the avirulent H/3’76 (small plaque phenotype) strains of swine vesicular disease virus to identify the genetic determinants of pathogenicity and plaque phenotype. Both traits could be mapped to the region between nucleotides (nt) 2233 and 3368 corresponding to the C terminus of VP3, the whole of VP1, and the N terminus of 2A. In this region, there are eight nucleotide differences leading to amino acid changes between the J1’73 and the H/3’76 strains. Site-directed mutagenesis of individual nucleotides from the virulent to the avirulent genotype and vice versa indicated that A at nt 2832, encoding glycine at VP1-132, and G at nt 3355, encoding arginine at 2APRO-20, correlated with a large-plaque phenotype and virulence in pigs, irrespective of the origin of the remainder of the genome. Of these two sites, 2APRO-20 appeared to be the dominant determinant for the large-plaque phenotype but further studies are required to elucidate their relative importance for virulence in pigs.
- 1 April 1999
- Published by American Society for Microbiology in Journal of Virology
- Vol. 73 (4) , 2710-2716
Mapping the Genetic Determinants of Pathogenicity and Plaque Phenotype in Swine Vesicular Disease Virus
A series of recombinant viruses were constructed using infectious cDNA clones of the virulent J1’73 (large plaque phenotype) and the avirulent H/3’76 (small plaque phenotype) strains of swine vesicular disease virus to identify the genetic determinants of pathogenicity and plaque phenotype. Both traits could be mapped to the region between nucleotides (nt) 2233 and 3368 corresponding to the C terminus of VP3, the whole of VP1, and the N terminus of 2A. In this region, there are eight nucleotide differences leading to amino acid changes between the J1’73 and the H/3’76 strains. Site-directed mutagenesis of individual nucleotides from the virulent to the avirulent genotype and vice versa indicated that A at nt 2832, encoding glycine at VP1-132, and G at nt 3355, encoding arginine at 2APRO-20, correlated with a large-plaque phenotype and virulence in pigs, irrespective of the origin of the remainder of the genome. Of these two sites, 2APRO-20 appeared to be the dominant determinant for the large-plaque phenotype but further studies are required to elucidate their relative importance for virulence in pigs.